A detailed history of Dunhill Financial, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Dunhill Financial, LLC holds 80 shares of DXCM stock, worth $6,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 38 110.53%
Holding current value
$6,419
Previous $4.26 Million 25.52%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$64.0 - $116.06 $2,688 - $4,874
42 Added 110.53%
80 $5.34 Million
Q2 2024

Aug 09, 2024

BUY
$110.31 - $140.45 $882 - $1,123
8 Added 26.67%
38 $4.26 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $571 - $700
5 Added 20.0%
30 $4.13 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $1,887 - $3,104
25 New
25 $3.11 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.